Ikarian Capital, LLC

Holdings History for Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Symbol: QNRX on Nasdaq
Investment type: Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Latest Disclosed Shares Owned: 211,538 shares
Security Ownership %: 13%

Shares, Excluding Options vs Price

Value, Excluding Options

Ikarian Capital, LLC ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

06 Feb 2026 - Ikarian Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 211,538 shares of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 13% ownership of the company. In their previous filing dated 15 Dec 2025, Ikarian Capital, LLC had reported owning 211,538 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Ikarian Capital, LLC	13%	-50%	$3,052,472	211,538	0		$14.43	13G/A	31 Jan 2026	06 Feb 2026, 17:28
Ikarian Capital, LLC	25%		$4,383,067	211,538			$20.72	13G	30 Nov 2025	15 Dec 2025, 21:53

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.4%	+0.4%	$3,052,493	211,538	+211,538	NEW	$14.43	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.